Development and launch in China of dotinurad for gout treatment
An individual drug development and commercialization theme advancing a Phase III trial, regulatory approval and launch in China for gout treatment with dotinurad (URECE).
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.